| Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B P Marcellin, GKK Lau, F Bonino, P Farci, S Hadziyannis, R Jin, ZM Lu, ... New England Journal of Medicine 351 (12), 1206-1217, 2004 | 1529 | 2004 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 702 | 2003 |
| Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B MR Brunetto, F Moriconi, F Bonino, GKK Lau, P Farci, C Yurdaydin, ... Hepatology 49 (4), 1141-1150, 2009 | 668 | 2009 |
| Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B M Sherman, C Yurdaydin, J Sollano, M Silva, YF Liaw, J Cianciara, ... Gastroenterology 130 (7), 2039-2049, 2006 | 604 | 2006 |
| A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel M Cornberg, HA Razavi, A Alberti, E Bernasconi, M Buti, C Cooper, ... Liver International 31, 30-60, 2011 | 589 | 2011 |
| Peginterferon plus adefovir versus either drug alone for hepatitis delta H Wedemeyer, C Yurdaydìn, GN Dalekos, A Erhardt, Y Çakaloğlu, ... New England Journal of Medicine 364 (4), 322-331, 2011 | 538 | 2011 |
| Ribavirin as therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial AM Di Bisceglie, HS Conjeevaram, MW Fried, R Sallie, Y Park, ... Annals of internal medicine 123 (12), 897-903, 1995 | 479 | 1995 |
| PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 64 (4), 800-806, 2016 | 456 | 2016 |
| Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial NV Bergasa, DW Alling, TL Talbot, MG Swain, C Yurdaydin, ML Turner, ... Annals of internal medicine 123 (3), 161-167, 1995 | 418 | 1995 |
| Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alfa-2a P Marcellin, F Bonino, GKK Lau, P Farci, C Yurdaydin, T Piratvisuth, R Jin, ... Gastroenterology 136 (7), 2169-2179. e4, 2009 | 413 | 2009 |
| Toward an improved definition of acute-on-chronic liver failure R Jalan, C Yurdaydin, JS Bajaj, SK Acharya, V Arroyo, HC Lin, P Gines, ... Gastroenterology 147 (1), 4-10, 2014 | 364 | 2014 |
| Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B F Bonino, P Marcellin, GKK Lau, S Hadziyannis, R Jin, T Piratvisuth, ... Gut 56 (5), 699-705, 2007 | 319 | 2007 |
| Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta B Heidrich, C Yurdaydın, G Kabacam, BA Ratsch, K Zachou, B Bremer, ... Hepatology 60 (1), 87-97, 2014 | 315 | 2014 |
| Late-onset Wilson’s disease P Ferenci, A Członkowska, U Merle, S Ferenc, G Gromadzka, ... Gastroenterology 132 (4), 1294-1298, 2007 | 311 | 2007 |
| The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ... Hepatology 66 (5), 1444-1453, 2017 | 309 | 2017 |
| Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial C Koh, L Canini, H Dahari, X Zhao, SL Uprichard, V Haynes-Williams, ... The Lancet Infectious Diseases 15 (10), 1167-1174, 2015 | 295 | 2015 |
| Entecavir therapy for lamivudine‐refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks M Sherman, C Yurdaydin, H Simsek, M Silva, YF Liaw, VK Rustgi, H Sette, ... Hepatology 48 (1), 99-108, 2008 | 220 | 2008 |
| Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C MS Sulkowski, C Cooper, B Hunyady, J Jia, P Ogurtsov, ... Nature reviews Gastroenterology & hepatology 8 (4), 212-223, 2011 | 216 | 2011 |
| Natural history and treatment of chronic delta hepatitis C Yurdaydın, R Idilman, H Bozkaya, AM Bozdayi Journal of viral hepatitis 17 (11), 749-756, 2010 | 208 | 2010 |
| Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission C Zimmermann, P Ferenci, C Pifl, C Yurdaydin, J Ebner, H Lassmann, ... Hepatology 9 (4), 594-601, 1989 | 208 | 1989 |
